More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

ArtemiC submitted to Health Canada

Apr 28, 2021 at 3:02 AM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Apr 28, 2021 at 3:02 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/artemic-submitted-to-health-canada

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

  • March quarterly activity and cashflow reportApr 26, 2021
  • MGC pharma to acquire medical research company MediCaNLApr 21, 2021
  • Investor presentationApr 9, 2021
  • Mxc completes first ArtemiC order, March qtr record revenueApr 6, 2021
  • Ethics Committee Approval Granted Phase III Clinical TrialMar 22, 2021

Later from Argent Biopharma

  • $1M order for ArtemiC Rescue from swiss PharmaCanMay 3, 2021
  • Further findings on ArtemiC as anti-inflammatory agentMay 7, 2021
  • CimetrA patent submitted to European IP officeMay 17, 2021
  • MGC pharma 2021 clinical trials program updateMay 24, 2021
  • CannEpil available for free dispensing in irelandJun 14, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer